Mittie Doyle

Chief Medical Officer, Avalo Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.0M

Companies

Latest trade

Aug 28, 2026

Companies

Avalo Therapeutics, Inc.Chief Medical Officer −$3.0M

Trades

AVTX Sold 679 shares at $20.00 · planned $0.0M Aug 28

AVTX Sold 1,000 shares at $20.00 · planned $0.0M Aug 17

AVTX Sold 679 shares at $20.00 · planned $0.0M Aug 10

AVTX Sold 1,000 shares at $20.00 · planned $0.0M Jul 27

AVTX Sold 4,654 shares at $20.00 · planned $0.1M Jun 30

AVTX Sold 1,450 shares at $18.00 · planned $0.0M Jun 23

AVTX Sold 679 shares at $16.00 · planned $0.0M May 28

AVTX Sold 3,000 shares at $18.76 · planned $0.1M May 15

AVTX Sold 106,555 shares at $20.68 · planned $2.2M May 6

AVTX Sold 1,679 shares at $16.00 · planned $0.0M May 5

AVTX Sold 3,970 shares at $18.01 · planned $0.1M Apr 6

AVTX Sold 679 shares at $16.00 · planned $0.0M Apr 1

AVTX Sold 25,492 shares at $16.15 · planned $0.4M Mar 16

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.